London Daily

Focus on the big picture.
Thursday, Jan 29, 2026

Competition regulator to investigate antibiotics price rise following surge in Strep A cases

Competition regulator to investigate antibiotics price rise following surge in Strep A cases

The CMA is "ready to take action" after stressing that it is illegal for companies to "charge excessive prices," amid reports one box of antibiotics was being sold for up to £19.
An investigation has been launched by the Competition and Markets Authority (CMA) following rocketing prices of antibiotics in the wake of Strep A cases.

Drug companies have been accused of hiking prices after some pharmacies said they were being charged up to £19 for a box of drugs that normally costs a few pounds.

Pharmacies say they are losing thousands per week as they can only recoup a fraction of the cost of drugs from the NHS.

They are also reporting that parents are having to go from pharmacy to pharmacy trying to find drugs for poorly children, as they struggle to get hold of antibiotics.

On Monday, the Department of Health issued a medicine supply notification for antibiotics for the treatment of Strep A. It said that supplies "may be temporarily limited in supply" at certain wholesalers and pharmacies.

This followed a statement by Health Secretary Steve Barclay, who said there was no shortage of antibiotics and stock could be moved around if any particular area was experiencing problems with supply.

Now, a spokesperson for the CMA has said: "People have got real concerns about the price of antibiotics used to treat Strep A, and we want companies to be clear about their obligations under the law.

"There should be no doubt that it is illegal for a dominant company to charge excessive prices, or for any companies to collude to drive up prices.

"We are working to establish the facts of what is currently happening in the market and welcome new information as part of our work.

"We stand ready to take action if there is evidence of anti-competitive behaviour that breaks the law."

Last week, one pharmaceutical leader told Sky News that shortages have been driven by "complicated supply chains" for medications and the raw materials used to make them, in many different parts of the world.

However, the industry has also seen "volatile spikes in demand for drugs" - following a sharp decline in demand during the COVID-19 pandemic, when people were not mixing or seeing GPs.

The Department of Health and Social Care told Sky News at the time, that it is "normal" for prices to "fluctuate based on demand".

The Association of Independent Multiple Pharmacies (AIMP) has urged the government to take action, as the problem is getting worse.

Faheem Ahmed told Sky News he had just three boxes of antibiotics - with many out of stock. He said in the 10 years since he qualified, he has never known a shortage of the drug.

"I hope it is temporary, but we are dealing with bacteria here, so when you say temporary, these bacteria multiply in minutes, seconds," he said.

"They are not going to wait for two, three, four days so whether it is temporary or long-term, if you look at it from a scientific level…the infection is going to spread."

A Department of Health and Social Care spokesman said on Wednesday: "Manufacturers currently have supplies of antibiotics available to treat Strep A.

"We continue to work urgently with manufacturers and wholesalers to expedite deliveries, bring forward stock they have to help ensure it gets to where it's needed and boost supply to meet demand as quickly as possible and support access to these vital medicines."
Newsletter

Related Articles

0:00
0:00
Close
Starmer Seeks Economic Gains From China Visit While Navigating US Diplomatic Sensitivities
Starmer Says China Visit Will Deliver Economic Benefits as He Prepares to Meet Xi Jinping
UK Prime Minister Starmer Arrives in China to Bolster Trade and Warn Firms of Strategic Opportunities
The AI Hiring Doom Loop — Algorithmic Recruiting Filters Out Top Talent and Rewards Average or Fake Candidates
Amazon to Cut 16,000 Corporate Jobs After Earlier 14,000 Reduction, Citing Streamlining and AI Investment
Federal Reserve Holds Interest Rate at 3.75% as Powell Faces DOJ Criminal Investigation During 2026 Decision
Putin’s Four-Year Ukraine Invasion Cost: Russia’s Mass Casualty Attrition and the Donbas Security-Guarantee Tradeoff
Wall Street Bets on Strong US Growth and Currency Moves as Dollar Slips After Trump Comments
UK Prime Minister Traveled to China Using Temporary Phones and Laptops to Limit Espionage Risks
Google’s $68 Million Voice Assistant Settlement Exposes Incentives That Reward Over-Collection
Kim Kardashian Admits Faking Paparazzi Visit to Britney Spears for Fame in Early 2000s
UPS to Cut 30,000 More Jobs by 2026 Amid Shift to High-Margin Deliveries
France Plans to Replace Teams and Zoom Across Government With Homegrown Visio by 2027
Trump Removes Minneapolis Deportation Operation Commander After Fatal Shooting of Protester
Iran’s Elite Wealth Abroad and Sanctions Leakage: How Offshore Luxury Sustains Regime Resilience
U.S. Central Command Announces Regional Air Exercise as Iran Unveils Drone Carrier Footage
Four Arrested in Andhra Pradesh Over Alleged HIV-Contaminated Injection Attack on Doctor
Hot Drinks, Hidden Particles: How Disposable Cups Quietly Increase Microplastic Exposure
UK Banks Pledge £11 Billion Lending Package to Help Firms Expand Overseas
Suella Braverman Defects to Reform UK, Accusing Conservatives of Betrayal on Core Policies
Melania Trump Documentary Sees Limited Box Office Traction in UK Cinemas
Meta and EssilorLuxottica Ray-Ban Smart Glasses and the Non-Consensual Public Recording Economy
WhatsApp Develops New Meta AI Features to Enhance User Control
Germany Considers Gold Reserves Amidst Rising Tensions with the U.S.
Michael Schumacher Shows Significant Improvement in Health Status
Greenland’s NATO Stress Test: Coercion, Credibility, and the New Arctic Bargaining Game
Diego Garcia and the Chagos Dispute: When Decolonization Collides With Alliance Power
Trump Claims “Total” U.S. Access to Greenland as NATO Weighs Arctic Basing Rights and Deterrence
Air France and KLM Suspend Multiple Middle East Routes as Regional Tensions Disrupt Aviation
U.S. winter storm triggers 13,000-plus flight cancellations and 160,000 power outages
Poland delays euro adoption as Domański cites $1tn economy and zloty advantage
White House: Trump warns Canada of 100% tariff if Carney finalizes China trade deal
PLA opens CMC probe of Zhang Youxia, Liu Zhenli over Xi authority and discipline violations
ICE and DHS immigration raids in Minneapolis: the use-of-force accountability crisis in mass deportation enforcement
UK’s Starmer and Trump Agree on Urgent Need to Bolster Arctic Security
Starmer Breaks Diplomatic Restraint With Firm Rebuke of Trump, Seizing Chance to Advocate for Europe
UK Finance Minister Reeves to Join Starmer on China Visit to Bolster Trade and Economic Ties
Prince Harry Says Sacrifices of NATO Forces in Afghanistan Deserve ‘Respect’ After Trump Remarks
Barron Trump Emerges as Key Remote Witness in UK Assault and Rape Trial
Nigel Farage Attended Davos 2026 Using HP Trust Delegate Pass Linked to Sasan Ghandehari
Gold Jumps More Than 8% in a Week as the Dollar Slides Amid Greenland Tariff Dispute
BlackRock Executive Rick Rieder Emerges as Leading Contender to Succeed Jerome Powell as Fed Chair
Boston Dynamics Atlas humanoid robot and LG CLOiD home robot: the platform lock-in fight to control Physical AI
United States under President Donald Trump completes withdrawal from the World Health Organization: health sovereignty versus global outbreak early-warning access
FBI and U.S. prosecutors vs Ryan Wedding’s transnational cocaine-smuggling network: the fight over witness-killing and cross-border enforcement
Trump Administration’s Iran Military Buildup and Sanctions Campaign Puts Deterrence Credibility on the Line
Apple and OpenAI Chase Screenless AI Wearables as the Post-iPhone Interface Battle Heats Up
Tech Brief: AI Compute, Chips, and Platform Power Moves Driving Today’s Market Narrative
NATO’s Stress Test Under Trump: Alliance Credibility, Burden-Sharing, and the Fight Over Strategic Territory
OpenAI’s Money Problem: Explosive Growth, Even Faster Costs, and a Race to Stay Ahead
×